The Scrutiny on Skin Substitutes: Shifting The Focus From Medicare Advantage

Jan 1, 2025
The Scrutiny on Skin Substitutes: Shifting The Focus From Medicare Advantage

While the top six major insurance companies have reported soaring profits—some rising by thousands of percentage points since the Medicare Advantage program was enacted, many patients enrolled in Medicare Advantage plans claim they didn’t even realize they were leaving traditional Medicare. This lack of transparency raises important questions about how these plans are marketed and the tactics used to encourage patients to switch.

Have you ever wondered why there is so much scrutiny on the use of skin substitutes to treat chronic wounds of Medicare patients? Is it purely coincidental that at the same time so much emphasis is being placed on how the wound care industry is regulated, Medicare Advantage enrollment has surged, outpacing traditional Medicare in many states? It’s interesting to note that OIG posted this late night on Wednesday night, and nobody even noticed because everybody is so focused on defending a small part of the Medicare expenditures – skin substitutes.

While the top six major insurance companies have reported soaring profits—some rising by thousands of percentage points since the Medicare Advantage program was enacted, many patients enrolled in Medicare Advantage plans claim they didn’t even realize they were leaving traditional Medicare. This lack of transparency raises important questions about how these plans are marketed and the tactics used to encourage patients to switch.

Representatives of the wound care industry aren’t even allowed to leave a pen in a provider’s office, while insurance companies have been providing nice incentives for to switch patients to Med Advantage or allegedly to allow agents of Med Advantage insurers access to their patient data to have their agents “encourage” patients to switch.  

This is particularly concerning when these recommendations may not be in the patient’s best interest. Many patients are unaware they’re opting out of the flexibility and breadth of coverage provided by traditional Medicare. As a result, those with higher health expenditure needs may find themselves facing unexpected expenses or coverage limitations down the line.  


Right now, we’re in the midst of Medicare’s open enrollment period—an ideal time to scrutinize the choices at hand. Providers should talk openly with their patients about the differences between Medicare Advantage and traditional Medicare. Specifically, if a patient is going to need expensive treatments not covered under a National Coverage Determination (NCD), like skin substitutes, or treatments that are covered, but under extremely restrictive policies determined by the MACs.  Patients (and their loved ones), in turn, should carefully research their options, ask tough questions, and avoid being swayed by enticing phone calls or marketing materials alone and ask instead, “What will my giving up traditional Medicare mean for me in terms of denied treatments that may be needed?”  

Key Takeaways for Patients & Their Families:

Ask Questions: Before signing up for Medicare Advantage, find out how it compares to traditional Medicare in terms of network restrictions, out-of-pocket costs, and coverage for specialized products and services, especially the care you may need.  

Stay Informed: Recognize that the aggressive push towards Medicare Advantage is motivated by profit.  Seek multiple sources of information—speak with trusted healthcare providers, read reputable articles, and consider consulting a Medicare counselor or benefits advisor who is not ultimately paid by insurers.  

Think Long-Term: If you anticipate higher healthcare expenditures in the future, remember that Medicare Advantage plans sometimes come with limits and may result in higher out-of-pocket costs for certain treatments or procedures.

Ultimately, understanding the forces behind Medicare Advantage’s growth and the potential consequences of enrolling in these plans is crucial. With the right information and guidance, patients and their families can make more informed decisions—ones that prioritize health, coverage, and financial well-being over insurance industry profits.

More News & Updates

Stay Up-To-Date With
Venture Medical

Aug 15, 2025

The price patients will pay for the PFS

After a recent survey we conducted, it is clear most clinicians agreed skin substitutes are highly effective and essential, warning that the proposed rates would reduce patient access, hinder innovation, and threaten the viability of many practices. Read the blog to learn more about our findings.

Aug 11, 2025

Skin Substitutes: An Inconvenient Truth

Proposed Medicare Cuts To Skin Substitutes Could Force Wound Care Clinicians Out, Putting Thousands of Patients at Risk.

Aug 4, 2025

The Case For Mobile Wound Care: An Essential Component Of Chronic Wound Management

Mobile wound care is a critical yet often misunderstood part of chronic wound management, providing advanced treatment to patients who can't easily access traditional care. Far from being a fringe service, it’s a large and growing field—with nearly 30,000 clinicians billing for mobile wound services in 2023 alone—and plays a key role in addressing the rising burden of chronic wounds, especially in nursing homes. As wound severity increases, staffing shortages persist, and the population ages, mobile providers are filling care gaps through high-volume, high-quality services and innovative tools like AI-assisted telehealth and near-infrared spectroscopy. To ensure better outcomes and lower healthcare costs, policymakers and payers must recognize mobile wound care as an essential, professional solution—not a peripheral one.

Jul 30, 2025
John Schroeder
John Schroeder

Venture Position on CMS and MAC Skin Substitute Proposals

Venture Medical, LCC is sharing our position on the CY2026 Medicare Physician Fee Schedule and our future recommendations.

Jul 23, 2025
John Schroeder & Howard Walthall
John Schroeder & Howard Walthall

How CMS Fudged the Math:

If we want reimbursement systems that reflect real-world care and outcomes, we need to speak up. The comment period is now open. Read the full breakdown from John Schroeder and Howard Walthall to learn more about how you can join the call for fair, evidence-based reimbursement.

Jul 11, 2025

The 2026 OPPS and PFS Rules: A Defining Moment for CAMPS Payment Reform

Venture Medical, a leader in wound care solutions, stands at the forefront of advocating for patient access and innovation in response to the 2026 Hospital Outpatient Prospective Payment System (OPPS) proposed rule.

Jul 7, 2025
Michael Schroeder
Michael Schroeder

Venture Medical Leads Investment in Plasmacure to Advance Breakthrough Cold Plasma Technology for Chronic Wound Healing

Venture Medical announces the closing of a strategic investment in Plasmacure B.V., the Dutch MedTech innovator behind PLASOMA, an award-winning cold plasma therapy for complex wound healing.

Jun 12, 2025
John Schroeder
John Schroeder

Venture Medical Announces Acquisition of Select ProgenaCare Global Assets to Expand Advanced Wound Care Portfolio

Venture Medical Announces Acquisition of Select ProgenaCare Global Assets to Expand Advanced Wound Care Portfolio

May 1, 2025

Venture Medical Announces Strategic Partnership with Plasmacure to Bring Groundbreaking Cold Plasma Therapy for Chronic Wounds to the U.S. Market

Apr 4, 2025

The hidden costs of limiting access: clinical and economic risks of Medicare’s future effective cellular, acellular and matrix-like products (CAMPs) Local Coverage Determination